‘Greed, greed, greed’: Sanders demands Ozempic maker lower prices
While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen. Bernie Sanders alleged that 40,000 people a year in the US could die if the company doesn’t make the medicines more affordable.
The health benefits of blockbuster weight loss drugs are bridging the stark political divide in the United States.
Novo Nordisk charges $969 per month for Ozempic in the U.S., compared ... they don't understand what happens with pricing a ...
Novo Nordisk’s blockbuster type 2 diabetes medication is a sure bet for the list of the next 15 drugs whose Medicare prices ...
Hidradenitis suppurativa is a lesion-causing inflammatory disorder that affects at least 1 in 100 people and is strongly ...
Novo Nordisk's blockbuster diabetes drug Ozempic will be eligible for U.S. government's price negotiations in less than a ...
A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly ...
No, if Novo Nordisk lowered their list price for Ozempic and Wegovy tomorrow to a price that was the same or lower than current net cost, that change by itself would not result in less favorable ...
Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of ...
An Australian celebrity was reportedly overheard telling others at a party how they allegedly got their hands on Ozempic to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback